After treatment with either P/MC or 2L PEG-3350 and bisacodyl tablets, no findings noted during physical examinations
were considered clinically significant. Data collected from ECGs in patients receiving P/MC and 2L PEG-3350
and bisacodyl tablets were reviewed centrally by experienced cardiologists and indicated no effect on AV conduction
or cardiac depolarization, as measured by PR and QRS interval durations, and no significant effect on cardiac rerepolarization as measured by QTcF.